Biology of Autism — Cascade Map

Biology of Autism — Cascade Map Caption

Cascade overview of the immune-derived autism cascade — from founding conditions and gut pH dysregulation through opioid peptide accumulation, LPS translocation, IDO1 activation, and NF-κB signalling to SST-14 interneuron silencing as the convergent node. The three disrupted neuropeptides — oxytocin, VIP, and secretin — and their downstream phenotype expressions are shown. For full molecular detail see Metabolic Pathways Explained.

🔄

Self-Sustaining Feedback Loop

Once established, the cascade no longer requires external triggers. SST-14 interneuron silencing removes the anti-inflammatory brake those interneurons normally exert — deepening the NF-κB/IDO1 inflammatory environment that is suppressing them. Quinolinic acid excitotoxicity depletes mitochondrial ATP in the remaining SST-14 interneurons, while adenosine accumulation from CD26 blockade suppresses cAMP/CREB from a second direction simultaneously. The gut barrier, compromised by opioid peptide fragments, continues feeding LPS into systemic circulation — sustaining the cytokine environment that drives both arms of SST-14 silencing. All mechanisms are self-reinforcing and self-perpetuating.

🧬

Intervention Logic — Working Upstream on Both Nodes

Because SST-14 interneuron silencing is driven simultaneously by IDO1 excitotoxicity, NF-κB CREB suppression, adenosine-driven cAMP deficit, and autoantibody surface receptor jamming, effective intervention must address multiple cascade points concurrently: infrastructure repair (sulforaphane, NAC, magnesium) → immune clearance (IMIG/IVIG) → metabolic restoration (NAD⁺ precursors, methylation support) → trophic restoration (BDNF, MSC support where needed). Single-target interventions are insufficient once the biological latch is engaged.

Infrastructure repair (Wave 1) → immune clearance (Wave 2) → metabolic restoration → trophic support (Wave 3) — sequence and state-specificity determine outcome

Upstream Triggers

Somatostatin (SST)

SST-14 Convergent Node

Reactive Glia

Synapse / Connectivity

ASD Features

Self-Sustaining Loop

STEP 01

Upstream Triggers

Maternal immune activation, gut dysbiosis with LPS translocation, mitochondrial dysfunction, and environmental exposures associated with increased ASD risk all generate sustained pro-inflammatory and metabolic stress signals reaching the developing brain. Importantly, MIA can impair SST-14 interneuron development in utero and epigenetically predispose the developing immune system toward NF-κB over-activation — meaning the cascade can be primed before birth, independent of any postnatal trigger.

MIA + Gut LPS + Mitochondrial ROS + Toxin exposure → chronic immune + metabolic stress

stress + inflammation → IDO1 induction + SST release simultaneously

STEP 01B

SST-14 Silenced — Neuropeptide Cascade Coordination Lost

The same upstream stressors initiate the two parallel arms of SST-14 interneuron silencing. Arm A: IDO1 activation generates quinolinic acid that drives NMDA excitotoxic calcium overload and NAD⁺ depletion in SST-14 interneurons. Arm B: NF-κB activation suppresses CREB transcriptionally, reducing SST-14 gene expression directly. Simultaneously, adenosine accumulation from CD26 blockade suppresses adenylyl cyclase through Gαi, reducing the cAMP that drives SST-14 transcription through the somatostatin gene's CRE. All three mechanisms converge on SST-14 silencing simultaneously.

Stress + Inflammation → SST ↑ → SSTR2/5 → AC ↓ → cAMP ↓ → PKA ↓ → CREB ↓ → BDNF ↓

IDO1 hijacks tryptophan → Arm A: QUIN → NMDA excitotoxicity → SST-14 energy depletion · Arm B: Serotonin↓ → PVN → Oxytocin↓

STEP 02

Tryptophan Hijack — Two Parallel Arms

Inflammation activates IDO1, diverting tryptophan away from serotonin synthesis into the kynurenine pathway. This creates two simultaneous downstream consequences that must be understood as distinct, not sequential.

Arm A — Excitotoxic: Quinolinic acid (a potent NMDA receptor agonist) accumulates, driving calcium overload into SST-14 interneurons. Mitochondrial ATP production fails under calcium stress. NAD⁺ is consumed by stress responses faster than the kynurenine pathway can replace it — SST-14 tonic firing cannot be sustained.

Arm 2 — Hypothalamic: Serotonin depletion impairs 5-HT2 receptor signaling in the hypothalamic paraventricular nucleus (PVN) — the brain's primary oxytocin synthesis site. Oxytocin release is suppressed, directly reducing social motivation, bonding, and affiliative behavior. NAD⁺ deficit additionally limits neuropeptide secretion capacity. Launay et al. 2023, n=271: NAD⁺ deficit strongly correlated with plasma oxytocin in ASD cohort.

Tryptophan → (IDO1) → Kynurenine → Arm A: QUIN ↑ → NMDA overactivation → Ca²⁺ overload → NAD⁺ ↓ → SST-14 ATP failure Arm B: Serotonin ↓ → PVN dysfunction → Oxytocin ↓

metabolic stress + NAD⁺ insufficiency → AMPK/mTOR dysregulation → cleanup failure

STEP 02B

Cellular Cleanup and Reset Failure

NAD⁺ depletion from IDO1 overactivation leaves AMPK under-supported while mTOR — the growth signal that suppresses autophagy — becomes relatively overactive. The cell's recycling system fails: damaged mitochondria are not cleared (impaired mitophagy), excess dendritic spines are not pruned, and inflammatory debris is not removed. This is the mechanism by which quinolinic acid excitotoxic pressure becomes chronic structural exhaustion in SST-14 interneurons — and why recovery requires mitochondrial energy restoration alongside immune clearance.

AMPK ↓ / mTOR ↑ → autophagy ↓ · mitophagy ↓ → damaged mito persist · spine excess · debris → NLRP3 + NF-κB re-activated

Quinolinic acid NMDA overactivation → calcium overload → mitochondrial ATP failure in SST-14 interneurons

STEP 03

SST-14 Interneuron Silencing — The Convergent Node

Four simultaneous suppressive mechanisms converge on SST-14 interneurons: (1) quinolinic acid NMDA excitotoxicity depleting mitochondrial ATP; (2) NF-κB suppressing CREB and SST-14 gene transcription; (3) adenosine from CD26 blockade suppressing adenylyl cyclase through Gαi, reducing cAMP/PKA/CREB; (4) autoantibodies jamming SST-14 interneuron surface receptors. With SST-14 output silenced, the anti-inflammatory brake is removed — deepening the inflammatory environment and closing the biological latch.

IDO1/QUIN + NF-κB + Adenosine/Gαi + Autoantibodies → SST-14 silenced → Oxytocin ↓ · VIP ↓ · Secretin ↓ [biological latch engaged]

NF-κB activation → IL-1β + TNF-α + C1q → glial state conversion

STEP 04

Reactive Glia

Unchecked NF-κB drives microglia to M1 pro-inflammatory states, releasing the IL-1β + TNF-α + C1q triad that converts astrocytes to A1 reactive phenotype. SST at glial SSTR2/5 receptors amplifies this shift — further suppressing astrocyte hevin and glypican output while elevating SPARC. Neuroinflammation is sustained and self-reinforcing: SST-14 loss removes the inhibitory brake on microglia, which produce more IL-1α/TNF-α/C1q, driving deeper A1 astrocyte polarisation, withdrawing hevin/SPARCL1 and BDNF, and further reducing trophic support for surviving SST-14 interneurons.

NF-κB → M1 Microglia → IL-1β + TNF-α + C1q → A1 Astrocytes [amplified by SST on glia]

A1 astrocytes + SST invert synaptogenic protein balance

STEP 05

Synapse Protein Imbalance

A1 astrocytes suppress hevin (synapse builder) and elevate SPARC (synapse pruner) while reducing glypican production (synapse maturer). SST at SSTR2/5 on astrocytes independently suppresses hevin and glypican secretion via a second route. Pruning dominates over building and maturation — the molecular architecture of synaptogenesis is inverted.

Hevin ↓ (A1 + SST) · SPARC ↑ (A1) · Glypicans ↓ (A1 + SST) → synapse formation impaired

aberrant synapse formation during critical developmental windows

STEP 06

Connectivity Shift

Reduced hevin preferentially impairs thalamocortical synaptogenesis — the circuit underlying sensory integration and social processing. Result: hyper-local connectivity within regions, reduced long-range integration across networks. Silent synapses from glypican deficit add functional impairment on top of structural deficit.

Thalamocortical synapses ↓ · Local connectivity ↑ · Long-range integration ↓ · Silent synapses persist

SST-14 silenced (four mechanisms) + A1 astrocyte polarisation + hevin/BDNF withdrawal → neuropeptide cascade disruption → observable phenotype

STEP 07

Autism Features

The downstream behavioral, sensory, cognitive, and physiological profile of autism emerges from the neural architecture and signaling state shaped by the cascade above. SST's gut effects additionally drive GI symptoms through a direct neuroendocrine route independent of neuroinflammation.

Social deficits have two distinct roots: (1) Long-range cortical connectivity failure — weakened thalamus→cortex relay paths from hevin deficit and synaptic pathology; (2) Hypothalamic oxytocin suppression via the IDO1→serotonin→PVN arm — reducing social motivation and affiliative drive at the neurochemical level. Interventions addressing only one root will produce only partial social gains.

Sensory reactivity · Social cognition (cortical + oxytocin) · Rigidity + CREB-impaired learning · GI disruption (SST + dysbiosis) · Sleep/mood

cascade becomes self-sustaining — loop closes

STEP 08

Self-Perpetuating Loop

Once established, the cascade no longer requires external triggers. Neuroinflammation sustains IDO1 → NAD⁺ depletion → mitochondrial ATP failure → SST-14 tonic firing fails → anti-inflammatory brake removed → neuroinflammation deepens. NF-κB suppresses CREB → SST-14 gene expression falls → coordinating output collapses → neuropeptide cascade disrupted. At the convergent node sits the Biological Latch: SST-14 silencing removes the mechanism that should correct it — the cascade is self-sustaining once the threshold is crossed.

The IDO1 node drives a second self-reinforcing loop through the hypothalamic arm: oxytocin suppression → reduced social engagement → stress elevation → further IDO1 activation → further serotonin depletion → further oxytocin suppression. This loop cannot be broken by interventions targeting only gut inflammation. All mechanisms — IDO1 excitotoxic arm, NF-κB transcriptional arm, CD26/adenosine/cAMP arm, and autoantibody arm — converge on SST-14 silencing and reinforce each other. Single-target interventions cannot break the latch once it is engaged.

Inflammation → IDO1 → QUIN ↑ → NMDA → SST-14 ATP failure · NF-κB → CREB ↓ → SST-14 gene ↓ · CD26 → Adenosine → Gαi → cAMP ↓ → CREB ↓ · IDO1 → Serotonin ↓ → Oxytocin ↓ → social stress ↑ → IDO1 ↑